These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 22295404)
1. Damage control surgery for liver rupture following selective internal radiation therapy for unresectable colorectal liver metastases. Latif E; Chua TC; Morris DL ANZ J Surg; 2011; 81(7-8):570-2. PubMed ID: 22295404 [No Abstract] [Full Text] [Related]
2. Yttrium-90 radioembolization is a viable treatment option for unresectable, chemorefractory colorectal cancer liver metastases: further evidence in support of a new treatment paradigm. Hickey R; Lewandowski R; Salem R Ann Surg Oncol; 2015 Mar; 22(3):706-7. PubMed ID: 25358665 [No Abstract] [Full Text] [Related]
3. Evidence-based integration of selective internal radiation therapy in the management of colorectal liver metastases. Wasan HS Future Oncol; 2014 Nov; 10(15 Suppl):33-6. PubMed ID: 25478764 [No Abstract] [Full Text] [Related]
13. Brachytherapy in the treatment of solitary colorectal metastases to the liver. Donath D; Nori D; Turnbull A; Kaufman N; Fortner JG J Surg Oncol; 1990 May; 44(1):55-61. PubMed ID: 2342376 [TBL] [Abstract][Full Text] [Related]
14. Resin 90Y-microsphere brachytherapy for unresectable colorectal liver metastases: modern USA experience. Kennedy AS; Coldwell D; Nutting C; Murthy R; Wertman DE; Loehr SP; Overton C; Meranze S; Niedzwiecki J; Sailer S Int J Radiat Oncol Biol Phys; 2006 Jun; 65(2):412-25. PubMed ID: 16690429 [TBL] [Abstract][Full Text] [Related]
15. Iodine-125 brachytherapy in the treatment of colorectal adenocarcinoma metastatic to the liver. Martinez-Monge R; Nag S; Nieroda CA; Martin EW Cancer; 1999 Mar; 85(6):1218-25. PubMed ID: 10189125 [TBL] [Abstract][Full Text] [Related]
16. Is yttrium-90 radioembolization a viable treatment option for unresectable, chemorefractory colorectal cancer liver metastases? A large single-center experience of 302 patients. Saxena A; Meteling B; Kapoor J; Golani S; Morris DL; Bester L Ann Surg Oncol; 2015 Mar; 22(3):794-802. PubMed ID: 25323474 [TBL] [Abstract][Full Text] [Related]
17. Liver function considerations for post-selective internal radiation therapy resection (hepatocellular carcinoma and metastatic colorectal cancer). Sangro B Future Oncol; 2014 Nov; 10(15 Suppl):57-9. PubMed ID: 25478769 [No Abstract] [Full Text] [Related]
18. Selective internal radiation therapy for colorectal liver metastases: cart before the horse or otherwise? Morris DL ANZ J Surg; 2006 Aug; 76(8):675. PubMed ID: 16916380 [No Abstract] [Full Text] [Related]
19. Local response and impact on survival after local ablation of liver metastases from colorectal carcinoma by computed tomography-guided high-dose-rate brachytherapy. Ricke J; Mohnike K; Pech M; Seidensticker M; Rühl R; Wieners G; Gaffke G; Kropf S; Felix R; Wust P Int J Radiat Oncol Biol Phys; 2010 Oct; 78(2):479-85. PubMed ID: 20304566 [TBL] [Abstract][Full Text] [Related]
20. Phase II feasibility study on the combination of two different regional treatment approaches in patients with colorectal "liver-only" metastases: hepatic interstitial brachytherapy plus regional chemotherapy. Wieners G; Pech M; Hildebrandt B; Peters N; Nicolaou A; Mohnike K; Seidensticker M; Sawicki M; Wust P; Ricke J Cardiovasc Intervent Radiol; 2009 Sep; 32(5):937-45. PubMed ID: 19472000 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]